MAPT and Alzheimer disease: Based on in silico modeling suggesting the existence of at least four binding sites on AD Tau fibrils [10] and different binding properties for the tau tracers, we utilized both 3H-THK5117 and 3H-MK6240 Tau tracers in the present study.